Developing informed consent content requires a lot of back and forth communication between multiple stakeholders - an inefficient, slow process with a history of allowing unapproved or out-of-date consents to be accidentally deployed to sites. Electronic Informed Consent (eConsent) offers a streamlined, collaborative process that promotes faster content development, approval and deployment on one platform, guaranteeing that only the most current and approved consent version is used each time.
Securing informed consent from clinical trial participants involves more than a signature—you need to ensure participants truly understand what they’re signing. Learn from industry expert, Sandra “SAM” Sather, on how the electronic informed consent (eConsent) process improves the way participants are consented on a clinical trial.
You may already know too well the challenges of a paper-based Informed Consent process, but did you know that Informed Consent is one of the most cited deficiencies by regulatory authorities? Paper-based informed consent increases your risk for delayed approvals, fines, litigation and even trial failure.
You may already know too well the challenges of a paper-based Informed Consent process, but did you know that Informed Consent is one of the most cited deficiencies by regulatory authorities? Paper-based informed consent increases your risk for delayed approvals, fines, litigation and even trial failure.
The informed consent process intends to ensure trial participants understand the risks and benefits of joining your trial, but a poor experience leads to low recruitment rates and costly drop-outs. Electronic Informed Consent (eConsent) improves recruitment and retention of participants by developing better comprehension of consent materials and improving engagement for the full duration of your study. In this short video, industry expert Sandra "Sam" Sather, reviews the ways that eConsent supports and adds value to the recruitment process.
|
|
|
|
|
|
|
|
|